Bio-Techne Corp (TECH)
77.29
+1.69
(+2.24%)
USD |
NASDAQ |
May 03, 16:00
77.31
+0.02
(+0.03%)
After-Hours: 20:00
Bio-Techne SG&A Expense (Quarterly): 111.84M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 111.84M |
December 31, 2023 | 115.67M |
September 30, 2023 | 105.33M |
June 30, 2023 | 60.81M |
March 31, 2023 | 99.24M |
December 31, 2022 | 93.01M |
September 30, 2022 | 99.38M |
June 30, 2022 | 62.86M |
March 31, 2022 | 89.27M |
December 31, 2021 | 100.69M |
September 30, 2021 | 86.18M |
June 30, 2021 | 51.61M |
March 31, 2021 | 82.60M |
December 31, 2020 | 83.12M |
September 30, 2020 | 72.60M |
June 30, 2020 | 37.52M |
March 31, 2020 | 66.32M |
December 31, 2019 | 68.03M |
September 30, 2019 | 69.01M |
June 30, 2019 | 41.24M |
March 31, 2019 | 64.97M |
December 31, 2018 | 63.60M |
September 30, 2018 | 67.05M |
June 30, 2018 | 18.83M |
March 31, 2018 | 53.28M |
Date | Value |
---|---|
December 31, 2017 | 63.78M |
September 30, 2017 | 58.29M |
June 30, 2017 | 1.512M |
March 31, 2017 | 49.41M |
December 31, 2016 | 56.98M |
September 30, 2016 | 45.42M |
June 30, 2016 | 38.04M |
March 31, 2016 | 35.22M |
December 31, 2015 | 34.58M |
September 30, 2015 | 33.04M |
June 30, 2015 | 9.395M |
March 31, 2015 | 29.09M |
December 31, 2014 | 31.14M |
September 30, 2014 | 28.70M |
June 30, 2014 | 17.10M |
March 31, 2014 | 14.67M |
December 31, 2013 | 14.93M |
September 30, 2013 | 14.02M |
June 30, 2013 | 12.12M |
March 31, 2013 | 9.982M |
December 31, 2012 | 10.96M |
September 30, 2012 | 10.33M |
June 30, 2012 | 10.36M |
March 31, 2012 | 9.899M |
December 31, 2011 | 10.65M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
37.52M
Minimum
Jun 2020
115.67M
Maximum
Dec 2023
79.82M
Average
82.86M
Median
SG&A Expense (Quarterly) Benchmarks
Agilent Technologies Inc | 396.00M |
Bio-Rad Laboratories Inc | 207.15M |
Revvity Inc | 260.57M |
Twist Bioscience Corp | 55.62M |
AIM ImmunoTech Inc | 10.86M |